Kazuko Shiozawa

2.0k total citations
59 papers, 1.4k citations indexed

About

Kazuko Shiozawa is a scholar working on Rheumatology, Immunology and Pathology and Forensic Medicine. According to data from OpenAlex, Kazuko Shiozawa has authored 59 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 33 papers in Rheumatology, 14 papers in Immunology and 12 papers in Pathology and Forensic Medicine. Recurrent topics in Kazuko Shiozawa's work include Rheumatoid Arthritis Research and Therapies (24 papers), Systemic Lupus Erythematosus Research (12 papers) and Monoclonal and Polyclonal Antibodies Research (10 papers). Kazuko Shiozawa is often cited by papers focused on Rheumatoid Arthritis Research and Therapies (24 papers), Systemic Lupus Erythematosus Research (12 papers) and Monoclonal and Polyclonal Antibodies Research (10 papers). Kazuko Shiozawa collaborates with scholars based in Japan, United States and South Korea. Kazuko Shiozawa's co-authors include Shunichi Shiozawa, Takuo Fujita, Yasushi Tanaka, Akira Hashiramoto, Shinichi Shimizu, Takeshi Fujita, Koichiro Komai, Yasushi Miura, Takashi Yamane and Kayo Osawa and has published in prestigious journals such as Journal of Biological Chemistry, Oncogene and Biochemical and Biophysical Research Communications.

In The Last Decade

Kazuko Shiozawa

55 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kazuko Shiozawa Japan 23 656 410 351 277 184 59 1.4k
Yoshinori Katada Japan 17 529 0.8× 462 1.1× 391 1.1× 333 1.2× 150 0.8× 46 1.4k
G. Yanni United Kingdom 18 1.0k 1.5× 660 1.6× 241 0.7× 275 1.0× 95 0.5× 26 1.8k
Keiko Yoshimoto Japan 24 555 0.8× 946 2.3× 272 0.8× 243 0.9× 183 1.0× 84 1.7k
Hirahito Endo Japan 24 302 0.5× 387 0.9× 407 1.2× 218 0.8× 133 0.7× 59 1.6k
Tue Wenzel Kragstrup Denmark 20 402 0.6× 538 1.3× 429 1.2× 290 1.0× 127 0.7× 71 1.4k
C. L. Verweij Netherlands 18 898 1.4× 764 1.9× 210 0.6× 260 0.9× 139 0.8× 27 1.9k
Kazuhiro Kurasawa Japan 26 692 1.1× 1.1k 2.8× 359 1.0× 207 0.7× 264 1.4× 81 2.4k
Masanori Kawashima Japan 19 722 1.1× 926 2.3× 636 1.8× 291 1.1× 119 0.6× 38 2.0k
Mitsuteru Akahoshi Japan 26 784 1.2× 1.4k 3.4× 365 1.0× 291 1.1× 391 2.1× 68 2.3k
Ruth Fritsch‐Stork Austria 23 680 1.0× 859 2.1× 234 0.7× 102 0.4× 116 0.6× 55 1.6k

Countries citing papers authored by Kazuko Shiozawa

Since Specialization
Citations

This map shows the geographic impact of Kazuko Shiozawa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kazuko Shiozawa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kazuko Shiozawa more than expected).

Fields of papers citing papers by Kazuko Shiozawa

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kazuko Shiozawa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kazuko Shiozawa. The network helps show where Kazuko Shiozawa may publish in the future.

Co-authorship network of co-authors of Kazuko Shiozawa

This figure shows the co-authorship network connecting the top 25 collaborators of Kazuko Shiozawa. A scholar is included among the top collaborators of Kazuko Shiozawa based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kazuko Shiozawa. Kazuko Shiozawa is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Fujimoto, Shino, Tomohiro Koga, Atsushi Kawakami, et al.. (2017). Tentative diagnostic criteria and disease severity classification for Castleman disease: A report of the research group on Castleman disease in Japan. Modern Rheumatology. 28(1). 161–167. 33 indexed citations
3.
Shiozawa, Kazuko, Takashi Yamane, Chihiro Tanaka, et al.. (2014). AB0394 Long Term Efficacy of Rheumatoid Arthritis (RA) Patients with Adequate Responses to Methotrexate (MTX) on Maintenance of Function and Structure: 3-Year Study Results. Annals of the Rheumatic Diseases. 73. 936–936.
4.
Tanaka, Chihiro, Kazuko Shiozawa, Akira Hashiramoto, & Shunichi Shiozawa. (2012). A study on the selection of DMARDs for the combination therapy with adalimumab.. PubMed. 58(2). E41–50. 1 indexed citations
5.
Hashiramoto, Akira, Kazuko Shiozawa, Yasushi Tanaka, et al.. (2009). Prospective study of methotrexate treatment for rheumatoid arthritis treated legitimately according to the government recommended 8 mg/week dose. Modern Rheumatology. 19(6). 637–642. 2 indexed citations
6.
Osawa, Kayo, Yasushi Miura, Koichiro Komai, et al.. (2006). Hypermethylated promoter region of DR3, the death receptor 3 gene, in rheumatoid arthritis synovial cells. Arthritis & Rheumatism. 54(3). 779–787. 103 indexed citations
8.
Shiozawa, Shunichi, Koichiro Komai, Kazuko Shiozawa, et al.. (2000). An approach to identify new genes in autoimmune diseases: lessons from rheumatoid arthritis.. PubMed. 2(1). 133–9. 2 indexed citations
9.
Shiozawa, Kazuko, et al.. (1999). Natural killer (NK) T cells are significantly decreased in the peripheral blood of patients with rheumatoid arthritis (RA). Clinical & Experimental Immunology. 118(1). 131–136. 67 indexed citations
10.
Maeda, Toshinaga, et al.. (1996). Adherence of synovial cells on EDA‐containing fibronectin. Arthritis & Rheumatism. 39(10). 1685–1692. 16 indexed citations
11.
Shiozawa, Shunichi, Yasuo Kuroki, Hitoshi Ishikawa, et al.. (1995). Eda‐containing fibronectin is synthesized from rheumatoid synovial fibroblast‐like cells. Arthritis & Rheumatism. 38(5). 678–683. 48 indexed citations
12.
Shiozawa, Shunichi, Ryouhei Yoshihara, Yasuo Kuroki, et al.. (1992). Pathogenic importance of fibronectin in the superficial region of articular cartilage as a local factor for the induction of pannus extension on rheumatoid articular cartilage.. Annals of the Rheumatic Diseases. 51(7). 869–873. 27 indexed citations
13.
Shiozawa, Shunichi, Kazuko Shiozawa, Masaki Kita, et al.. (1992). A PRELIMINARY STUDY ON THE EFFECT OF ALPHA-INTERFERON TREATMENT ON THE JOINT INFLAMMATION AND SERUM CALCIUM IN RHEUMATOID ARTHRITIS. Lara D. Veeken. 31(6). 405–408. 13 indexed citations
14.
Shiozawa, Kazuko, et al.. (1992). Methotrexate induced early onset pancytopenia in rheumatoid arthritis: drug allergy? Idiosyncrasy?. PubMed. 19(8). 1320–1. 13 indexed citations
15.
Shiozawa, Shunichi, Kazuko Shiozawa, Satoru Shimizu, et al.. (1990). IMMUNOREACTIVE CIRCULATING ALPHA-INTERFERON IS LOW IN SJÖGREN'S SYNDROME. Lara D. Veeken. 29(1). 50–52. 18 indexed citations
16.
Saigo, Katsuyasu, Shunichi Shiozawa, Kazuko Shiozawa, et al.. (1988). Alpha-interferon treatment for adult T cell leukemia: low levels of circulating alpha-interferon and it's clinical effectiveness. Annals of Hematology. 56(2). 83–86. 10 indexed citations
17.
18.
Shiozawa, Shunichi, Kazuko Shiozawa, Yasushi Tanaka, & Takuo Fujita. (1987). 1α, 25-dihydroxyvitamin D3 inhibits proliferative response of T-and B-lymphocytes in a serum-free culture. International Journal of Immunopharmacology. 9(6). 719–723. 14 indexed citations
19.
Shiozawa, Shunichi, K Chihara, Kazuko Shiozawa, et al.. (1986). A sensitive radioimmunoassay for alpha-interferon: circulating alpha-interferon-like substance in the plasma of healthy individuals and rheumatoid arthritis patients.. PubMed. 66(1). 77–87. 29 indexed citations
20.
Shiozawa, Kazuko, et al.. (1981). Improvement of plasma exchange for rheumatic diseases adsorbent for rheumatoid factor and immune complexes in plasma. Artificial Organs. 5. 79. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026